Support Groups – Safe Harbor Behavioral Health has introduced SafeLine, an anti-bullying hotline for students who are victims of bullying. The service is immediately Anonymous user intervention to support 24 hours a day.
This can save your life
|
|
PET CT Applications in Non-Neoplastic Conditions (Annals of the New York Academy of Sciences) $79.68 PET-CT imaging is a powerful tool in diagnosis and treatment of cancer. Its application as a prognostic tool in various malignancies is well established. This volume encompasses the latest trends and developments of PET-CT imaging in non-neoplastic disease along with its application in clinical decision-making. This volume will be of interest to internal medicine specialists and subspecialists, as… |
|
|
Immunomodulation as a potential therapeutic approach for Alzheimer’s disease. $49.99 Alzheimer’s disease (AD) is the most prevalent form of progressive dementia and is characterized by the accumulation of amyloid beta (Abeta) peptide in the brain and in the cerebral vessels forming cerebral amyloid angiopathy (CAA). As previously reported, an active immunization strategy of mice with Abeta1-42 peptide results in decreased Th1 and increased Th2 cytokine responses as well as an effectively clearance of CNS Abeta. This approach has also yielded favorable results for many patients, unfortunately, a small percentage of these study participants developed severe aseptic meningoencephalitis likely secondary to CNS invasion of activated T-cells. We have previously demonstrated that disruption of CD40-40L pathway reduces Abeta plaque load, promotes Th2 response, and rescues from cognitive impairments. However, direct blockage of the CD40 pathway by passive vaccination with anti-CD40L antibody leads to immunosupression. Therefore, in its current form this therapeutic strategy poses an unacceptable risk to the recipient of treatment, aged individual. For those reasons, the identification and characterization of alternative modulators/inhibitors of CD40 signaling may be necessary for the development of safe and effective AD immunotherapy.;This proposal introduces novel immunomodulatory therapies that are based on previous vaccination strategies or cell based therapies across medial field. We showed that transcutaneous vaccination can both be efficacious and safe, thus clearly demonstrating that the right combination of the antigens, adjuvants, and the routes of administration are crucial for the right vaccine. Furthermore, we demonstrated that the effects of current Abeta vaccine strategies could be enhanced by a simultaneous blockade of CD40-40L signaling. As an alternative approach, we explored the possibility of cell-based therapies and showed that human umbilical cord blood cells, which are currently used as a treatment for systemic lupus erythematosus and |
|
|
Inflammatory Disorders of the Nervous System: Pathogenesis, Immunology, and Clinical Management $7.38 Now well recognized, the critical role of the inflammatory response in the pathophysiology of peripheral and central neurological disorders, including Alzheimer’s and Parkinson’s diseases, is today the subject of intense investigation at the molecular level. In Inflammatory Disorders of the Nervous System: Pathogenesis, Immunology, and Clinical Management, a panel of influential basic scientists review in detail the fundamental biological principles underlying the more common inflammatory disorders of the nervous system. The authors provide extensive updates on the latest findings concerning the mechanisms of inflammation and introduce such new concepts and methodologies as “endothelial and leukocyte microparticles” and “gene microarray technology” to help explain important links between the central nervous system (CNS) and general inflammatory processes. Among the diseases examined from an inflammatory perspective are multiple sclerosis, acute disseminated encephalomyelitis, optic neuritis, transverse myelitis, CNS vasculitis, neuropsychiatric systemic lupus erythematosis, Alzheimer’s disease, and Parkinson’s disease. The role of the immune system in neuroinflammation is also explored in such disorders as neurosarcoidosis, HIV-associated dementia, and HTLV-associated neurological disorders. Cutting-edge and authoritative, Inflammatory Disorders of the Nervous System: Pathogenesis, Immunology, and Clinical Management offers basic research and clinical scientists an illuminating introduction to the new world of inflammatory CNS conditions and the emerging diagnostic and therapeutic opportunities they provide. |